Karyopharm Therapeutics Inc.
News
Karyopharm Therapeutics (NASDAQ:KPTI) Stock Crosses Below Two Hundred Day Moving Average of $1.06
Zolmax Karyopharm Therapeutics Inc. (NASDAQ:KPTI - Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.06 and...\n more…
Down -12.14% in 4 Weeks, Here's Why Karyopharm Therapeutics (KPTI) Looks Ripe for a Turnaround
Zacks Investment Research Karyopharm Therapeutics (KPTI) has been beaten down lately with too much selling pressure. While the stock has lost 12.1% over the past four weeks, there is light at the end of the tunnel as it is...\n more…
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire NEWTON...\n more…
Karyopharm to Participate at Upcoming Investor Conferences
PR Newswire Karyopharm to Participate at Upcoming Investor Conferences Karyopharm to Participate at Upcoming Investor Conferences PR Newswire NEWTON, Mass., Sept. 3, 2024 NEWTON, Mass., Sept. 3, 2024...\n more…
Michael Mason Resigns as CFO of Karyopharm Therapeutics
TipRanks Financial Blog Karyopharm Therapeutics (KPTI) has shared an update. Michael Mason has announced his resignation as Executive Vice President, Chief Financial Officer, and Treasurer...\n more…